Global Infusion Pump Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024
Global infusion pump market is expected to grow significantly from USD 9,210 million in 2017 to USD 14,500 million in 2024, at a thriving CAGR of 6.6% from 2018 to 2024.
The growth in the market is attributed to the growing incidence of chronic diseases, and increasing number of surgical procedures performed across the globe. Moreover, rising demand in ambulatory settings, and continuous technological innovations in pump technology coupled with new product launches are also driving the market growth. The years used for the assessment are as follows:
Historical year: 2014, 2015 and 2016
Base year: 2017
Forecast period: 2018 – 2024
The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;
Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total global infusion pump market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global infusion pump market
Finalizing the overall size and share of the global infusion pump market
To analyze market trends, opportunities, drivers, and restraints associated with the global infusion pump market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the global infusion pump market and provide their competitive landscape
The research scope for global infusion pump market is as follows:
By Products Type
Patient-controlled analgesia (PCA) Pumps
Immune deficiency disorder,
Nephrology & urological disorder
By Channel Type
Research and Laboratory
Ambulatory surgical centers
Home care settings
Central & South America
Middle East and Africa (MEA)
The major growth driver in the global infusion pump market is the growing incidence of chronic diseases, and increasing number of surgical procedure performed across the globe. Moreover, rising demand in the ambulatory settings, owing to growing number of surgical procedure performed in also driving the market growth. Additionally, growing prevalence of diabetes across the globe, as well as increasing awareness towards insulin delivering devices is also augmenting the growth of the infusion pump market.
Infusion pump is a medical device that is capable of delivering nutrients, antibiotics, insulin, chemotherapy or pain relief drugs and other medications into the patient’s body in a controlled amount. Approximately, millions of infusion pumps are used around the world in various end-user segments such as home setting, hospital, clinics, laboratory, and ambulatory surgical centers. The infusion pump plays the important role in providing preoperative care, critical care, and pain management.
Geographically, North America held the largest share of the market in 2017. The growth in the region is attributed to the increasing prevalence of chronic diseases and rising adoption of infusion pump device. Moreover, growing number of hospitals and ambulatory surgical centers has also resulted in increased usage of infusion pump in the region. Technological advancement in smart infusion pump and presence of major players in the region is further boosting the market growth. The growth of infusion pump market in the Europe is primarily due to the increasing number of diabetic patients, and introduction of new products in the region. Asia-Pacific is expected to witness the highest CAGR during the forecast period owing to growing healthcare expenditure.
Some of the key companies operating in the market include Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Medtronic, Baxter International Inc., Medical International Limited, Terumo Corporation, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Becton, Dickinson and Company, and ICU Medical, Inc.